Cyteph was last night awarded $1.5m from the Australian Federal Government’s Medical Research Future Fund – via a clinical CUREator grant – to advance the treatment landscape for an aggressive form of brain cancer.
The Australian’s Tim Dodd has published an article summarising the Medical Research Future Fund CUREator funding announcement.
Cyteph received a $1.5m grant last night, a significant boost for the Company’s efforts to positively contribute to the cancer therapeutics space.
